Lam Research Corporation Stock Price and Value Analysis

Lam Research Corporation (NasdaqGS:LRCX) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Lam Research Corporation to reach your target.

Target type

LRCX Free Cash Flow Trend

Free Cash Flow trendline for LRCX
Free Cash Flow trendline for Lam Research Corporation
CSV

Based on historical returns, we believe that Lam Research Corporation can grow its free cash at a rate of about 22%. That's positive!

AdvantagesDisadvantages
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has a low dividend yield.

Inside the LRCX Numbers

LRCX Price
(Lam Research Corporation stock price per share)
$203.68
[?] LRCX Fair Price
(based on intrinsic value)
$48.04
[?] LRCX Safety Price (based on a variable margin of safety) $28.82
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 131% higher than other Industrials stocks
[?] PE Ratio versus Industry 61% higher than other Specialty Industrial Machinery stocks
[?] Cash Yield 0.34%
[?] Free Cash Flow Jitter 26%
[?] Dividend Yield 0.52% (tax impact)
Shares Shorted 27,501,835

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 27,501,835 shares shorted. With 1,244,274,250 shares available for purchase and an average trading volume over the past 10 trading days of 13,934,550, it would take at least 2.0 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 707549 -122
2010 707549 311
2011 707549 812
2012 707549 420
2013 707549 625
2014 707549 602
2015 707549 638
2016 707549 1,193
2017 707549 1,862
2018 707549 2,466
2019 707549 2,954
2020 707549 1,904
2021 707549 3,331
2022 707549 2,765
2023 707549 4,798
2024 707549 4,253
2025 707549 5,663
2026 707549 5,224

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2009 to 2026 with positive net income, operating cash flow totaled $43,841 million against net income of $41,553 million, or 1.06 times. Net income was negative in 1 of the 18 years, and those years are left out of the ratio.

In 2026, operating cash flow was 0.81 times net income, compared with 1.15 times for the earliest three years (2009 to 2011).

In 2026, capital expenditures were $966 million, 16.5% of operating cash flow of $5,858 million, which leaves an estimated $4,891 million after capex. Across the 17 years with reported capex, it averaged 12.3% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Cash conversion in 2026 was 0.81, at least 0.25 under the 1.15 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 -302 -78.1 44.3 n/a
2010 347 351 35.6 1.01
2011 724 881 127 1.22
2012 169 499 107 2.96
2013 114 720 161 6.32
2014 632 717 146 1.13
2015 656 786 198 1.20
2016 914 1,350 175 1.48
2017 1,698 2,029 157 1.20
2018 2,381 2,656 273 1.12
2019 2,191 3,176 303 1.45
2020 2,252 2,126 203 0.94
2021 3,908 3,588 349 0.92
2022 4,605 3,100 546 0.67
2023 4,511 5,179 502 1.15
2024 3,828 4,652 397 1.22
2025 5,358 6,173 759 1.15
2026 7,265 5,858 966 0.81

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2017 to 2026 with dividend or share repurchase facts, estimated free cash flow totaled $35,219 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $7,776 million, 22.1% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $27,312 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2026, dividends and cash spent repurchasing shares together were $5,122 million, 98.1% of estimated free cash flow of $5,224 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2017 1,862 243 812 1,055 56.7%
2018 2,466 308 2,653 2,961 120.1%
2019 2,954 678 3,781 4,459 150.9%
2020 1,904 657 1,370 2,026 106.4%
2021 3,331 727 2,698 3,425 102.8%
2022 2,765 815 3,866 4,681 169.3%
2023 4,798 908 2,017 2,925 61.0%
2024 4,253 1,019 2,843 3,862 90.8%
2025 5,663 1,150 3,422 4,572 80.7%
2026 5,224 1,271 3,851 5,122 98.1%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,116 million in 2009 and $23,233 million in 2026, a compound annual growth rate of 19.6% over 17 years. The starting revenue was under 10% of the latest, so that rate comes from a small base and says little about recent growth.

Revenue rose 26.0% from 2025 to 2026.

Our estimated free cash flow was $5,224 million in 2026, 22.5% of revenue. In 2009 the estimated margin was negative 11.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 1,116 -122 -11.0%
2010 2,134 311 14.6%
2011 3,238 812 25.1%
2012 2,665 420 15.8%
2013 3,599 625 17.4%
2014 4,607 602 13.1%
2015 5,259 638 12.1%
2016 5,886 1,193 20.3%
2017 8,014 1,862 23.2%
2018 11,077 2,466 22.3%
2019 9,654 2,954 30.6%
2020 10,045 1,904 19.0%
2021 14,626 3,331 22.8%
2022 17,227 2,765 16.0%
2023 17,429 4,798 27.5%
2024 14,905 4,253 28.5%
2025 18,436 5,663 30.7%
2026 23,233 5,224 22.5%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2026, cash and equivalents were $5,579 million against total liabilities of $11,059 million, or 50.4% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 47.0% of total assets in 2026, compared with 28.9% in 2010, an increase of 18.1 percentage points.

Stockholders equity was $12,471 million in 2026, compared with $1,768 million in 2010, a rise of 605.3%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 43.5% in 2026. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 2,487 546 719 1,768
2011 4,054 1,492 1,584 2,470
2012 8,005 1,565 2,873 5,132
2013 7,250 1,162 2,761 4,489
2014 7,993 1,453 2,964 5,030
2015 9,365 1,502 4,262 5,103
2016 12,264 5,039 6,370 5,895
2017 12,123 2,378 5,305 6,817
2018 12,479 4,512 5,978 6,502
2019 12,001 3,658 7,327 4,674
2020 14,559 4,915 9,387 5,172
2021 15,892 4,418 9,865 6,027
2022 17,196 3,522 10,917 6,278
2023 18,782 5,337 10,571 8,210
2024 18,745 5,848 10,205 8,539
2025 21,345 6,391 11,484 9,862
2026 23,530 5,579 11,059 12,471

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $203.68, our model's value equals that price if free cash flow grows an average of 45.2 percent a year over the 10 projection years. Our model assumes 21.6 percent a year for this stock, so the price implies growth of 45.2 percent, which is above the 21.6 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 45.2 percent a year, free cash flow would grow about 41.7 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $866 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $162.94 41.6%
Current price $203.68 45.2%
20 percent above the current price $244.42 48.2%
Our model (stored fair price) $48.04 21.6%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Of the 18 fiscal years we can see for Lam Research Corporation under its current filer, 17 show positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $333 million at the start and $5,046 million most recently.

Year-to-year variability in free cash flow is uneven, measured at 26%.

Lam Research Corporation is priced at $203.68, above our fair value estimate of $48.04 and its safe value of $28.82.

Lam Research Corporation yields 0.52% in dividends.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 131% above the average for stocks in the Industrials sector.

Its trailing P/E ratio is 61% above the average for stocks in the Specialty Industrial Machinery industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Specialty Industrial Machinery industry, the ones closest in market capitalization to Lam Research Corporation, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Lam Research Corporation (LRCX) 254,431 30.4 0.5% 0.3% 324% above
Eaton Corporation plc (ETN) 128,426 33.0 1.3% 0.8% 247% above
Johnson Controls International plc (JCI) 81,627 28.8 1.2% 0.8% 270% above
Cummins (CMI) 55,295 16.8 2.0% 3.2% 8% above
Xylem (XYL) 21,842 21.1 1.8% 1.2% 38% above
nVent Electric plc (NVT) 16,457 24.7 0.8% - 583% above
IDEX Corporation (IEX) 16,133 30.5 1.3% 2.5% 30% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 707549.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 1 of the 18 years we have.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2026
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: LRCX annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in LRCX

Does Lam Research Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LRCX

This example shows how we apply the Trendshare checklist to LRCX: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 203.68
    • Market cap: $254B
    • EPS: 6.71
  2. Step 2 — Valuation checks

    • P/E: 30.355
    • FCF yield: 0.3%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.